TY  - CHAP
M1  - Book, Section
TI  - Subcutaneous casirivimab and imdevimab reduced symptomatic COVID-19 infection among asymptomatic positive individuals
A1  - Engel, Jake
A1  - Pratte, Michael
PY  - 2015
T2  - 2 Minute Medicine
AB  - 
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/24
UR  - accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=580013
ER  -